FDA pushes forward on gene-editing therapies with new safety roadmap
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Move strengthens footprint in Western India and expands multi-specialty care network
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
Subscribe To Our Newsletter & Stay Updated